Metraipolis › archive › dc_8a466db1e089
4C-I — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/4C-I
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-06T17:05:51.309Z
- SHA-256 of the archived text
1f62622c2c27c3ed3fe8b130edeb558f044439447150e9973bab0b4f75b338e7- Stable URL of this page
https://metraipolis.com/documento/dc_8a466db1e089
How to cite
4C-I — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/4C-I (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_8a466db1e089 (Metraipolis archive dc_8a466db1e089, sha256 1f62622c2c27c3ed3fe8b130edeb558f044439447150e9973bab0b4f75b338e7)
BibTeX
@misc{dc8a466db1e089,
title = {4C-I — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/4C-I},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_8a466db1e089; sha256 1f62622c2c27c3ed3fe8b130edeb558f044439447150e9973bab0b4f75b338e7},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/4C-I. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
4C-I, also known as iodo-Ariadne, 4C-DOI, or DOI-B, as well as 4-iodo-2,5-dimethoxy-α-ethylphenethylamine, is a serotonin 5-HT2 receptor agonist of the phenethylamine, phenylisobutylamine, and 4C families related to Ariadne (4C-D). It is a close analogue of the psychedelic drugs 2C-I and DOI, with 2C-I having no substitution at the α carbon, DOI having an α-methyl group, and 4C-I having an α-ethyl group. In his 1991 book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin described testing 4C-I at doses of up to 4 mg orally, but observed no effects and did not assess higher doses. The drug is a potent agonist of the serotonin 5-HT2A receptor. It shows similar efficacy as an agonist of this receptor as Ariadne, but has 12- to 16-fold higher activational potency in comparison. Like Ariadne, 4C-I produces an attenuated head-twitch response relative to the psychedelic drug DOPR, with a similar maximal response as Ariadne. The chemical synthesis of 4C-I has been described. 4C-I first described in the scientific literature by Alexander Shulgin and colleagues in 1977. Subsequently, it was described in greater detail by Michael Cunningham and colleagues in 2023. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «4C-I» — https://en.wikipedia.org/wiki/4C-I Wikidata Q138008344: «pharmaceutical compound» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q138008344 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/4C-I?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1371210500, consultata il 2026-11-06T17:01:49.650Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: fe1cf461d77f8600d5177f7879eedf6ec0444888931512fd6ec6a7e527bd368a